Linked Data API

Show Search Form

Search Results

425122
registered interest false more like this
date less than 2015-10-30more like thismore than 2015-10-30
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Respiratory System: Diseases more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, if he will assess the (a) potential effect on the number of antibiotic and (b) potential change in annual prescription and dispensing costs prescriptions of using C-reactive protein testing for patients presenting with respiratory tract infections in primary care. more like this
tabling member constituency Erewash more like this
tabling member printed
Maggie Throup remove filter
uin 14222 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2015-11-09more like thismore than 2015-11-09
answer text <p>We have no plans to do so.</p><br /><p>The UK Government is committed to tackling antimicrobial resistance. The UK Antimicrobial Resistance Strategy, published in September 2013, proposed strong, cross-government action to manage this problem. The UK strategy recognises the central part diagnostics, like C-reactive protein tests, play in getting the right antibiotic drug to the right patient at the right time. A working group is actively looking at what can be done to improve diagnostic services.</p><p><strong></strong></p> more like this
answering member constituency Mid Norfolk more like this
answering member printed George Freeman more like this
question first answered
less than 2015-11-09T16:11:41.6Zmore like thismore than 2015-11-09T16:11:41.6Z
answering member
4020
label Biography information for George Freeman more like this
tabling member
4447
label Biography information for Maggie Throup more like this